nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—SHBG—prostate cancer	0.0846	0.318	CbGaD
Fluoxymesterone—AR—prostate cancer	0.0742	0.279	CbGaD
Fluoxymesterone—ESR1—prostate cancer	0.0571	0.215	CbGaD
Fluoxymesterone—NR3C1—prostate cancer	0.0503	0.189	CbGaD
Fluoxymesterone—AR—Nilutamide—prostate cancer	0.0451	0.133	CbGbCtD
Fluoxymesterone—AR—Bicalutamide—prostate cancer	0.0451	0.133	CbGbCtD
Fluoxymesterone—Testosterone—Abiraterone—prostate cancer	0.044	0.169	CrCrCtD
Fluoxymesterone—AR—Flutamide—prostate cancer	0.0374	0.11	CbGbCtD
Fluoxymesterone—ESR1—Estramustine—prostate cancer	0.0362	0.106	CbGbCtD
Fluoxymesterone—SHBG—Estrone—prostate cancer	0.0323	0.0949	CbGbCtD
Fluoxymesterone—SHBG—Ethinyl Estradiol—prostate cancer	0.0288	0.0846	CbGbCtD
Fluoxymesterone—Testosterone Propionate—Estradiol valerate/Dienogest—prostate cancer	0.0248	0.0954	CrCrCtD
Fluoxymesterone—ESR1—Estrone—prostate cancer	0.0233	0.0686	CbGbCtD
Fluoxymesterone—ESR1—Ethinyl Estradiol—prostate cancer	0.0208	0.0612	CbGbCtD
Fluoxymesterone—Testolactone—Estrone—prostate cancer	0.0187	0.0719	CrCrCtD
Fluoxymesterone—SHBG—Estradiol—prostate cancer	0.0185	0.0545	CbGbCtD
Fluoxymesterone—Testosterone—Estramustine—prostate cancer	0.0183	0.0704	CrCrCtD
Fluoxymesterone—Danazol—Ethinyl Estradiol—prostate cancer	0.0169	0.0651	CrCrCtD
Fluoxymesterone—AR—Estradiol—prostate cancer	0.0155	0.0456	CbGbCtD
Fluoxymesterone—ESR1—Conjugated Estrogens—prostate cancer	0.0153	0.0449	CbGbCtD
Fluoxymesterone—Norethindrone—Ethinyl Estradiol—prostate cancer	0.0147	0.0566	CrCrCtD
Fluoxymesterone—Testosterone—Estrone—prostate cancer	0.0145	0.0559	CrCrCtD
Fluoxymesterone—ESR1—Estradiol—prostate cancer	0.0134	0.0394	CbGbCtD
Fluoxymesterone—Methyltestosterone—Ethinyl Estradiol—prostate cancer	0.0121	0.0465	CrCrCtD
Fluoxymesterone—Testosterone—Estradiol—prostate cancer	0.011	0.0424	CrCrCtD
Fluoxymesterone—NR3C1—Prednisone—prostate cancer	0.00849	0.0249	CbGbCtD
Fluoxymesterone—Potassium Canrenoate—Prednisone—prostate cancer	0.00703	0.0271	CrCrCtD
Fluoxymesterone—Danazol—Prednisone—prostate cancer	0.00593	0.0229	CrCrCtD
Fluoxymesterone—Hydrocortamate—Prednisone—prostate cancer	0.00516	0.0199	CrCrCtD
Fluoxymesterone—Cortisone acetate—Prednisone—prostate cancer	0.005	0.0193	CrCrCtD
Fluoxymesterone—Testolactone—Prednisone—prostate cancer	0.00485	0.0187	CrCrCtD
Fluoxymesterone—Amcinonide—Prednisone—prostate cancer	0.00446	0.0172	CrCrCtD
Fluoxymesterone—Fludrocortisone—Prednisone—prostate cancer	0.00434	0.0167	CrCrCtD
Fluoxymesterone—Clobetasol propionate—Prednisone—prostate cancer	0.00434	0.0167	CrCrCtD
Fluoxymesterone—Methyltestosterone—Prednisone—prostate cancer	0.00424	0.0163	CrCrCtD
Fluoxymesterone—PRLR—prostate gland—prostate cancer	0.00423	0.164	CbGeAlD
Fluoxymesterone—Desoximetasone—Prednisone—prostate cancer	0.00413	0.0159	CrCrCtD
Fluoxymesterone—Mometasone—Prednisone—prostate cancer	0.00403	0.0155	CrCrCtD
Fluoxymesterone—Fluprednidene Acetate—Prednisone—prostate cancer	0.00403	0.0155	CrCrCtD
Fluoxymesterone—Fluorometholone—Prednisone—prostate cancer	0.00403	0.0155	CrCrCtD
Fluoxymesterone—Loteprednol—Prednisone—prostate cancer	0.00403	0.0155	CrCrCtD
Fluoxymesterone—Triamcinolone—Prednisone—prostate cancer	0.00403	0.0155	CrCrCtD
Fluoxymesterone—Dexamethasone—Prednisone—prostate cancer	0.00394	0.0152	CrCrCtD
Fluoxymesterone—Betamethasone—Prednisone—prostate cancer	0.00394	0.0152	CrCrCtD
Fluoxymesterone—Prednisolone—Prednisone—prostate cancer	0.00369	0.0142	CrCrCtD
Fluoxymesterone—SHBG—semen—prostate cancer	0.00365	0.141	CbGeAlD
Fluoxymesterone—Hydrocortisone—Prednisone—prostate cancer	0.00354	0.0136	CrCrCtD
Fluoxymesterone—AR—penis—prostate cancer	0.00275	0.106	CbGeAlD
Fluoxymesterone—AR—semen—prostate cancer	0.00262	0.101	CbGeAlD
Fluoxymesterone—PRLR—testis—prostate cancer	0.00187	0.0722	CbGeAlD
Fluoxymesterone—Coma hepatic—Docetaxel—prostate cancer	0.0014	0.0288	CcSEcCtD
Fluoxymesterone—Coma hepatic—Capecitabine—prostate cancer	0.00135	0.0279	CcSEcCtD
Fluoxymesterone—NR3C1—urine—prostate cancer	0.00132	0.0513	CbGeAlD
Fluoxymesterone—Hirsutism—Estrone—prostate cancer	0.00126	0.0261	CcSEcCtD
Fluoxymesterone—Hirsutism—Estradiol valerate/Dienogest—prostate cancer	0.0011	0.0228	CcSEcCtD
Fluoxymesterone—Clotting—Conjugated Estrogens—prostate cancer	0.000951	0.0196	CcSEcCtD
Fluoxymesterone—SHBG—prostate gland—prostate cancer	0.000914	0.0354	CbGeAlD
Fluoxymesterone—Blood cholesterol increased—Goserelin—prostate cancer	0.000851	0.0176	CcSEcCtD
Fluoxymesterone—Hirsutism—Bicalutamide—prostate cancer	0.000848	0.0175	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Estrone—prostate cancer	0.000837	0.0173	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Flutamide—prostate cancer	0.000774	0.016	CcSEcCtD
Fluoxymesterone—Clotting—Estradiol—prostate cancer	0.000761	0.0157	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Estradiol valerate/Dienogest—prostate cancer	0.00073	0.0151	CcSEcCtD
Fluoxymesterone—Polycythaemia—Prednisone—prostate cancer	0.000692	0.0143	CcSEcCtD
Fluoxymesterone—Gynaecomastia—Estramustine—prostate cancer	0.000689	0.0142	CcSEcCtD
Fluoxymesterone—AR—prostate gland—prostate cancer	0.000656	0.0254	CbGeAlD
Fluoxymesterone—ESR1—prostate gland—prostate cancer	0.000644	0.0249	CbGeAlD
Fluoxymesterone—Gynaecomastia—Nilutamide—prostate cancer	0.000611	0.0126	CcSEcCtD
Fluoxymesterone—Gynaecomastia—Flutamide—prostate cancer	0.000608	0.0126	CcSEcCtD
Fluoxymesterone—Libido decreased—Estramustine—prostate cancer	0.000602	0.0124	CcSEcCtD
Fluoxymesterone—Hirsutism—Goserelin—prostate cancer	0.00059	0.0122	CcSEcCtD
Fluoxymesterone—Hirsutism—Conjugated Estrogens—prostate cancer	0.000584	0.0121	CcSEcCtD
Fluoxymesterone—Oligospermia—Epirubicin—prostate cancer	0.000564	0.0116	CcSEcCtD
Fluoxymesterone—AR—seminal vesicle—prostate cancer	0.000555	0.0215	CbGeAlD
Fluoxymesterone—Disturbance in sexual arousal—Estramustine—prostate cancer	0.000554	0.0114	CcSEcCtD
Fluoxymesterone—Gynaecomastia—Degarelix—prostate cancer	0.000546	0.0113	CcSEcCtD
Fluoxymesterone—Libido decreased—Nilutamide—prostate cancer	0.000534	0.011	CcSEcCtD
Fluoxymesterone—Libido decreased—Flutamide—prostate cancer	0.000532	0.011	CcSEcCtD
Fluoxymesterone—Oligospermia—Doxorubicin—prostate cancer	0.000521	0.0108	CcSEcCtD
Fluoxymesterone—Seborrhoeic dermatitis—Goserelin—prostate cancer	0.000503	0.0104	CcSEcCtD
Fluoxymesterone—Libido decreased—Estradiol valerate/Dienogest—prostate cancer	0.000502	0.0104	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Nilutamide—prostate cancer	0.000492	0.0102	CcSEcCtD
Fluoxymesterone—Menstruation irregular—Estradiol—prostate cancer	0.000491	0.0101	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Flutamide—prostate cancer	0.00049	0.0101	CcSEcCtD
Fluoxymesterone—AR—epithelium—prostate cancer	0.000482	0.0187	CbGeAlD
Fluoxymesterone—Libido decreased—Degarelix—prostate cancer	0.000477	0.00986	CcSEcCtD
Fluoxymesterone—NR3C1—prostate gland—prostate cancer	0.000475	0.0184	CbGeAlD
Fluoxymesterone—Amenorrhoea—Ethinyl Estradiol—prostate cancer	0.000474	0.00979	CcSEcCtD
Fluoxymesterone—ESR1—epithelium—prostate cancer	0.000473	0.0183	CbGeAlD
Fluoxymesterone—SHBG—bone marrow—prostate cancer	0.000471	0.0182	CbGeAlD
Fluoxymesterone—Hirsutism—Estradiol—prostate cancer	0.000468	0.00966	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Estradiol valerate/Dienogest—prostate cancer	0.000462	0.00954	CcSEcCtD
Fluoxymesterone—AR—renal system—prostate cancer	0.000447	0.0173	CbGeAlD
Fluoxymesterone—Gynaecomastia—Bicalutamide—prostate cancer	0.000441	0.00911	CcSEcCtD
Fluoxymesterone—AR—urethra—prostate cancer	0.000439	0.017	CbGeAlD
Fluoxymesterone—Disturbance in sexual arousal—Degarelix—prostate cancer	0.000439	0.00907	CcSEcCtD
Fluoxymesterone—ESR1—renal system—prostate cancer	0.000439	0.017	CbGeAlD
Fluoxymesterone—Azoospermia—Epirubicin—prostate cancer	0.000438	0.00906	CcSEcCtD
Fluoxymesterone—Coagulopathy—Conjugated Estrogens—prostate cancer	0.000436	0.00901	CcSEcCtD
Fluoxymesterone—Azoospermia—Doxorubicin—prostate cancer	0.000406	0.00838	CcSEcCtD
Fluoxymesterone—SHBG—testis—prostate cancer	0.000403	0.0156	CbGeAlD
Fluoxymesterone—NR3C1—seminal vesicle—prostate cancer	0.000402	0.0156	CbGeAlD
Fluoxymesterone—Amenorrhoea—Goserelin—prostate cancer	0.00039	0.00806	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Conjugated Estrogens—prostate cancer	0.000387	0.00798	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Conjugated Estrogens—prostate cancer	0.000387	0.00798	CcSEcCtD
Fluoxymesterone—Libido decreased—Bicalutamide—prostate cancer	0.000386	0.00797	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Bicalutamide—prostate cancer	0.000355	0.00733	CcSEcCtD
Fluoxymesterone—NR3C1—epithelium—prostate cancer	0.000349	0.0135	CbGeAlD
Fluoxymesterone—Coagulopathy—Estradiol—prostate cancer	0.000349	0.00721	CcSEcCtD
Fluoxymesterone—Alopecia—Estramustine—prostate cancer	0.000341	0.00705	CcSEcCtD
Fluoxymesterone—Libido decreased—Ethinyl Estradiol—prostate cancer	0.000326	0.00674	CcSEcCtD
Fluoxymesterone—NR3C1—renal system—prostate cancer	0.000324	0.0125	CbGeAlD
Fluoxymesterone—NR3C1—urethra—prostate cancer	0.000318	0.0123	CbGeAlD
Fluoxymesterone—Menstruation irregular—Docetaxel—prostate cancer	0.000316	0.00653	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Estradiol—prostate cancer	0.000309	0.00639	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Estradiol—prostate cancer	0.000309	0.00639	CcSEcCtD
Fluoxymesterone—Gynaecomastia—Goserelin—prostate cancer	0.000307	0.00634	CcSEcCtD
Fluoxymesterone—Alopecia—Nilutamide—prostate cancer	0.000303	0.00626	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Ethinyl Estradiol—prostate cancer	0.0003	0.0062	CcSEcCtD
Fluoxymesterone—Hirsutism—Capecitabine—prostate cancer	0.000292	0.00602	CcSEcCtD
Fluoxymesterone—AR—testis—prostate cancer	0.000289	0.0112	CbGeAlD
Fluoxymesterone—Amenorrhoea—Mitoxantrone—prostate cancer	0.000288	0.00595	CcSEcCtD
Fluoxymesterone—Anxiety—Estramustine—prostate cancer	0.000285	0.0059	CcSEcCtD
Fluoxymesterone—ESR1—testis—prostate cancer	0.000284	0.011	CbGeAlD
Fluoxymesterone—Menstruation irregular—Prednisone—prostate cancer	0.000273	0.00563	CcSEcCtD
Fluoxymesterone—Alopecia—Degarelix—prostate cancer	0.000271	0.00559	CcSEcCtD
Fluoxymesterone—Libido decreased—Goserelin—prostate cancer	0.000268	0.00554	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Estrone—prostate cancer	0.000262	0.00542	CcSEcCtD
Fluoxymesterone—Hirsutism—Prednisone—prostate cancer	0.00026	0.00537	CcSEcCtD
Fluoxymesterone—Alopecia—Cabazitaxel—prostate cancer	0.000255	0.00527	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Conjugated Estrogens—prostate cancer	0.000255	0.00526	CcSEcCtD
Fluoxymesterone—Anxiety—Flutamide—prostate cancer	0.000252	0.00521	CcSEcCtD
Fluoxymesterone—Haemoglobin—Bicalutamide—prostate cancer	0.000249	0.00514	CcSEcCtD
Fluoxymesterone—Haemorrhage—Bicalutamide—prostate cancer	0.000248	0.00511	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Goserelin—prostate cancer	0.000247	0.0051	CcSEcCtD
Fluoxymesterone—NR3C1—bone marrow—prostate cancer	0.000245	0.00948	CbGeAlD
Fluoxymesterone—Gynaecomastia—Estradiol—prostate cancer	0.000243	0.00502	CcSEcCtD
Fluoxymesterone—Anxiety—Estradiol valerate/Dienogest—prostate cancer	0.000238	0.00491	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Estradiol valerate/Dienogest—prostate cancer	0.000229	0.00473	CcSEcCtD
Fluoxymesterone—Paraesthesia—Nilutamide—prostate cancer	0.000219	0.00452	CcSEcCtD
Fluoxymesterone—Alopecia—Bicalutamide—prostate cancer	0.000219	0.00452	CcSEcCtD
Fluoxymesterone—Coagulopathy—Capecitabine—prostate cancer	0.000218	0.0045	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Degarelix—prostate cancer	0.000218	0.00449	CcSEcCtD
Fluoxymesterone—Anxiety—Cabazitaxel—prostate cancer	0.000213	0.0044	CcSEcCtD
Fluoxymesterone—Libido decreased—Estradiol—prostate cancer	0.000213	0.0044	CcSEcCtD
Fluoxymesterone—Haemoglobin—Ethinyl Estradiol—prostate cancer	0.00021	0.00434	CcSEcCtD
Fluoxymesterone—AR—lymph node—prostate cancer	0.00021	0.00811	CbGeAlD
Fluoxymesterone—NR3C1—testis—prostate cancer	0.000209	0.00811	CbGeAlD
Fluoxymesterone—Haemorrhage—Ethinyl Estradiol—prostate cancer	0.000209	0.00432	CcSEcCtD
Fluoxymesterone—ESR1—lymph node—prostate cancer	0.000206	0.00797	CbGeAlD
Fluoxymesterone—Anaphylactoid reaction—Estradiol—prostate cancer	0.000204	0.00421	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Docetaxel—prostate cancer	0.000199	0.00412	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Estradiol—prostate cancer	0.000196	0.00404	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Mitoxantrone—prostate cancer	0.00019	0.00392	CcSEcCtD
Fluoxymesterone—Alopecia—Ethinyl Estradiol—prostate cancer	0.000185	0.00382	CcSEcCtD
Fluoxymesterone—Paraesthesia—Cabazitaxel—prostate cancer	0.000184	0.0038	CcSEcCtD
Fluoxymesterone—Anxiety—Bicalutamide—prostate cancer	0.000183	0.00378	CcSEcCtD
Fluoxymesterone—Seborrhoeic dermatitis—Epirubicin—prostate cancer	0.000173	0.00358	CcSEcCtD
Fluoxymesterone—Haemoglobin—Goserelin—prostate cancer	0.000173	0.00357	CcSEcCtD
Fluoxymesterone—Haemorrhage—Goserelin—prostate cancer	0.000172	0.00356	CcSEcCtD
Fluoxymesterone—Headache—Estramustine—prostate cancer	0.000172	0.00355	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Prednisone—prostate cancer	0.000172	0.00355	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Estradiol valerate/Dienogest—prostate cancer	0.000169	0.00348	CcSEcCtD
Fluoxymesterone—Headache—Estrone—prostate cancer	0.000164	0.00339	CcSEcCtD
Fluoxymesterone—Nausea—Estramustine—prostate cancer	0.000163	0.00337	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Degarelix—prostate cancer	0.00016	0.00331	CcSEcCtD
Fluoxymesterone—Seborrhoeic dermatitis—Doxorubicin—prostate cancer	0.00016	0.00331	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Etoposide—prostate cancer	0.000158	0.00326	CcSEcCtD
Fluoxymesterone—Paraesthesia—Bicalutamide—prostate cancer	0.000158	0.00326	CcSEcCtD
Fluoxymesterone—Nausea—Estrone—prostate cancer	0.000156	0.00322	CcSEcCtD
Fluoxymesterone—Anxiety—Ethinyl Estradiol—prostate cancer	0.000155	0.00319	CcSEcCtD
Fluoxymesterone—Headache—Nilutamide—prostate cancer	0.000153	0.00315	CcSEcCtD
Fluoxymesterone—Alopecia—Goserelin—prostate cancer	0.000152	0.00314	CcSEcCtD
Fluoxymesterone—Headache—Flutamide—prostate cancer	0.000152	0.00314	CcSEcCtD
Fluoxymesterone—NR3C1—lymph node—prostate cancer	0.000152	0.00588	CbGeAlD
Fluoxymesterone—Hypersensitivity—Cabazitaxel—prostate cancer	0.000151	0.00312	CcSEcCtD
Fluoxymesterone—Alopecia—Conjugated Estrogens—prostate cancer	0.000151	0.00311	CcSEcCtD
Fluoxymesterone—Amcinonide—ANXA1—prostate cancer	0.000146	0.0523	CrCbGaD
Fluoxymesterone—Nausea—Nilutamide—prostate cancer	0.000145	0.00299	CcSEcCtD
Fluoxymesterone—Nausea—Flutamide—prostate cancer	0.000144	0.00298	CcSEcCtD
Fluoxymesterone—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000143	0.00296	CcSEcCtD
Fluoxymesterone—Haemoglobin—Estradiol—prostate cancer	0.000137	0.00283	CcSEcCtD
Fluoxymesterone—Haemorrhage—Estradiol—prostate cancer	0.000137	0.00282	CcSEcCtD
Fluoxymesterone—Headache—Degarelix—prostate cancer	0.000136	0.00282	CcSEcCtD
Fluoxymesterone—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000136	0.00281	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Epirubicin—prostate cancer	0.000134	0.00278	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Epirubicin—prostate cancer	0.000134	0.00278	CcSEcCtD
Fluoxymesterone—Libido decreased—Capecitabine—prostate cancer	0.000133	0.00274	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Bicalutamide—prostate cancer	0.00013	0.00268	CcSEcCtD
Fluoxymesterone—Nausea—Degarelix—prostate cancer	0.000129	0.00267	CcSEcCtD
Fluoxymesterone—Headache—Cabazitaxel—prostate cancer	0.000128	0.00265	CcSEcCtD
Fluoxymesterone—Haemoglobin—Mitoxantrone—prostate cancer	0.000128	0.00264	CcSEcCtD
Fluoxymesterone—Haemorrhage—Mitoxantrone—prostate cancer	0.000127	0.00263	CcSEcCtD
Fluoxymesterone—Anxiety—Goserelin—prostate cancer	0.000127	0.00263	CcSEcCtD
Fluoxymesterone—Anxiety—Conjugated Estrogens—prostate cancer	0.000126	0.0026	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Doxorubicin—prostate cancer	0.000124	0.00257	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Doxorubicin—prostate cancer	0.000124	0.00257	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Goserelin—prostate cancer	0.000122	0.00253	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Capecitabine—prostate cancer	0.000122	0.00252	CcSEcCtD
Fluoxymesterone—Nausea—Cabazitaxel—prostate cancer	0.000122	0.00252	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Conjugated Estrogens—prostate cancer	0.000121	0.0025	CcSEcCtD
Fluoxymesterone—Alopecia—Estradiol—prostate cancer	0.000121	0.00249	CcSEcCtD
Fluoxymesterone—Medroxyprogesterone Acetate—HSD3B2—prostate cancer	0.00012	0.043	CrCbGaD
Fluoxymesterone—Alopecia—Mitoxantrone—prostate cancer	0.000112	0.00232	CcSEcCtD
Fluoxymesterone—Headache—Bicalutamide—prostate cancer	0.00011	0.00228	CcSEcCtD
Fluoxymesterone—Paraesthesia—Goserelin—prostate cancer	0.00011	0.00227	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.00011	0.00226	CcSEcCtD
Fluoxymesterone—Paraesthesia—Conjugated Estrogens—prostate cancer	0.000109	0.00225	CcSEcCtD
Fluoxymesterone—Stanozolol—AR—prostate cancer	0.000104	0.0374	CrCbGaD
Fluoxymesterone—Nausea—Bicalutamide—prostate cancer	0.000104	0.00216	CcSEcCtD
Fluoxymesterone—Anxiety—Estradiol—prostate cancer	0.000101	0.00208	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Estradiol—prostate cancer	9.7e-05	0.002	CcSEcCtD
Fluoxymesterone—Oxandrolone—AR—prostate cancer	9.41e-05	0.0336	CrCbGaD
Fluoxymesterone—Anxiety—Mitoxantrone—prostate cancer	9.39e-05	0.00194	CcSEcCtD
Fluoxymesterone—Alopecia—Etoposide—prostate cancer	9.35e-05	0.00193	CcSEcCtD
Fluoxymesterone—Headache—Ethinyl Estradiol—prostate cancer	9.31e-05	0.00192	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Mitoxantrone—prostate cancer	9.04e-05	0.00187	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Goserelin—prostate cancer	9.01e-05	0.00186	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Conjugated Estrogens—prostate cancer	8.93e-05	0.00184	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Epirubicin—prostate cancer	8.86e-05	0.00183	CcSEcCtD
Fluoxymesterone—Haemoglobin—Docetaxel—prostate cancer	8.84e-05	0.00183	CcSEcCtD
Fluoxymesterone—Nausea—Ethinyl Estradiol—prostate cancer	8.83e-05	0.00182	CcSEcCtD
Fluoxymesterone—Haemorrhage—Docetaxel—prostate cancer	8.79e-05	0.00182	CcSEcCtD
Fluoxymesterone—Paraesthesia—Estradiol—prostate cancer	8.71e-05	0.0018	CcSEcCtD
Fluoxymesterone—Haemoglobin—Capecitabine—prostate cancer	8.56e-05	0.00177	CcSEcCtD
Fluoxymesterone—Haemorrhage—Capecitabine—prostate cancer	8.51e-05	0.00176	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Doxorubicin—prostate cancer	8.2e-05	0.00169	CcSEcCtD
Fluoxymesterone—Paraesthesia—Mitoxantrone—prostate cancer	8.11e-05	0.00168	CcSEcCtD
Fluoxymesterone—Alopecia—Docetaxel—prostate cancer	7.77e-05	0.0016	CcSEcCtD
Fluoxymesterone—Headache—Goserelin—prostate cancer	7.66e-05	0.00158	CcSEcCtD
Fluoxymesterone—Haemoglobin—Prednisone—prostate cancer	7.62e-05	0.00157	CcSEcCtD
Fluoxymesterone—Headache—Conjugated Estrogens—prostate cancer	7.59e-05	0.00157	CcSEcCtD
Fluoxymesterone—Haemorrhage—Prednisone—prostate cancer	7.58e-05	0.00157	CcSEcCtD
Fluoxymesterone—Alopecia—Capecitabine—prostate cancer	7.52e-05	0.00155	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Etoposide—prostate cancer	7.52e-05	0.00155	CcSEcCtD
Fluoxymesterone—Nausea—Goserelin—prostate cancer	7.27e-05	0.0015	CcSEcCtD
Fluoxymesterone—Nausea—Conjugated Estrogens—prostate cancer	7.2e-05	0.00149	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Estradiol—prostate cancer	7.15e-05	0.00148	CcSEcCtD
Fluoxymesterone—Paraesthesia—Etoposide—prostate cancer	6.75e-05	0.00139	CcSEcCtD
Fluoxymesterone—Alopecia—Prednisone—prostate cancer	6.7e-05	0.00138	CcSEcCtD
Fluoxymesterone—Medroxyprogesterone Acetate—AKR1C3—prostate cancer	6.66e-05	0.0238	CrCbGaD
Fluoxymesterone—Hypersensitivity—Mitoxantrone—prostate cancer	6.66e-05	0.00138	CcSEcCtD
Fluoxymesterone—Anxiety—Capecitabine—prostate cancer	6.29e-05	0.0013	CcSEcCtD
Fluoxymesterone—Testosterone Propionate—CYP17A1—prostate cancer	6.28e-05	0.0225	CrCbGaD
Fluoxymesterone—Anaphylactic shock—Docetaxel—prostate cancer	6.25e-05	0.00129	CcSEcCtD
Fluoxymesterone—Hydrocortisone—ANXA1—prostate cancer	6.16e-05	0.022	CrCbGaD
Fluoxymesterone—Headache—Estradiol—prostate cancer	6.08e-05	0.00125	CcSEcCtD
Fluoxymesterone—Testosterone—CYP3A43—prostate cancer	6e-05	0.0215	CrCbGaD
Fluoxymesterone—Haemoglobin—Epirubicin—prostate cancer	5.96e-05	0.00123	CcSEcCtD
Fluoxymesterone—Haemorrhage—Epirubicin—prostate cancer	5.93e-05	0.00122	CcSEcCtD
Fluoxymesterone—Testolactone—CYP19A1—prostate cancer	5.88e-05	0.021	CrCbGaD
Fluoxymesterone—Dexamethasone—CYP3A43—prostate cancer	5.81e-05	0.0208	CrCbGaD
Fluoxymesterone—Nausea—Estradiol—prostate cancer	5.76e-05	0.00119	CcSEcCtD
Fluoxymesterone—Headache—Mitoxantrone—prostate cancer	5.66e-05	0.00117	CcSEcCtD
Fluoxymesterone—Paraesthesia—Docetaxel—prostate cancer	5.61e-05	0.00116	CcSEcCtD
Fluoxymesterone—Anxiety—Prednisone—prostate cancer	5.6e-05	0.00116	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Etoposide—prostate cancer	5.54e-05	0.00114	CcSEcCtD
Fluoxymesterone—Haemoglobin—Doxorubicin—prostate cancer	5.52e-05	0.00114	CcSEcCtD
Fluoxymesterone—Haemorrhage—Doxorubicin—prostate cancer	5.49e-05	0.00113	CcSEcCtD
Fluoxymesterone—Paraesthesia—Capecitabine—prostate cancer	5.43e-05	0.00112	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Prednisone—prostate cancer	5.39e-05	0.00111	CcSEcCtD
Fluoxymesterone—Nausea—Mitoxantrone—prostate cancer	5.37e-05	0.00111	CcSEcCtD
Fluoxymesterone—Alopecia—Epirubicin—prostate cancer	5.24e-05	0.00108	CcSEcCtD
Fluoxymesterone—Testosterone Propionate—COMT—prostate cancer	5.12e-05	0.0183	CrCbGaD
Fluoxymesterone—Alopecia—Doxorubicin—prostate cancer	4.85e-05	0.001	CcSEcCtD
Fluoxymesterone—Paraesthesia—Prednisone—prostate cancer	4.84e-05	0.000999	CcSEcCtD
Fluoxymesterone—Headache—Etoposide—prostate cancer	4.71e-05	0.000973	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Docetaxel—prostate cancer	4.6e-05	0.000951	CcSEcCtD
Fluoxymesterone—Dexamethasone—ANXA1—prostate cancer	4.59e-05	0.0164	CrCbGaD
Fluoxymesterone—Nausea—Etoposide—prostate cancer	4.46e-05	0.000922	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Capecitabine—prostate cancer	4.46e-05	0.00092	CcSEcCtD
Fluoxymesterone—Desoximetasone—NR3C1—prostate cancer	4.4e-05	0.0157	CrCbGaD
Fluoxymesterone—Anxiety—Epirubicin—prostate cancer	4.38e-05	0.000905	CcSEcCtD
Fluoxymesterone—Loteprednol—NR3C1—prostate cancer	4.34e-05	0.0155	CrCbGaD
Fluoxymesterone—Eplerenone—CYP3A5—prostate cancer	4.31e-05	0.0154	CrCbGaD
Fluoxymesterone—Fludrocortisone—AR—prostate cancer	4.28e-05	0.0153	CrCbGaD
Fluoxymesterone—Anaphylactic shock—Epirubicin—prostate cancer	4.21e-05	0.00087	CcSEcCtD
Fluoxymesterone—Anxiety—Doxorubicin—prostate cancer	4.05e-05	0.000837	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Prednisone—prostate cancer	3.97e-05	0.00082	CcSEcCtD
Fluoxymesterone—Headache—Docetaxel—prostate cancer	3.91e-05	0.000808	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Doxorubicin—prostate cancer	3.9e-05	0.000805	CcSEcCtD
Fluoxymesterone—Danazol—SHBG—prostate cancer	3.85e-05	0.0138	CrCbGaD
Fluoxymesterone—Testosterone Propionate—AR—prostate cancer	3.82e-05	0.0136	CrCbGaD
Fluoxymesterone—Headache—Capecitabine—prostate cancer	3.79e-05	0.000783	CcSEcCtD
Fluoxymesterone—Paraesthesia—Epirubicin—prostate cancer	3.78e-05	0.000781	CcSEcCtD
Fluoxymesterone—Hydrocortamate—NR3C1—prostate cancer	3.72e-05	0.0133	CrCbGaD
Fluoxymesterone—Nausea—Docetaxel—prostate cancer	3.71e-05	0.000766	CcSEcCtD
Fluoxymesterone—Spironolactone—SHBG—prostate cancer	3.69e-05	0.0132	CrCbGaD
Fluoxymesterone—Cortisone acetate—NR3C1—prostate cancer	3.66e-05	0.0131	CrCbGaD
Fluoxymesterone—Nausea—Capecitabine—prostate cancer	3.59e-05	0.000742	CcSEcCtD
Fluoxymesterone—Megestrol acetate—NR3C1—prostate cancer	3.53e-05	0.0126	CrCbGaD
Fluoxymesterone—Paraesthesia—Doxorubicin—prostate cancer	3.5e-05	0.000723	CcSEcCtD
Fluoxymesterone—Medroxyprogesterone Acetate—SHBG—prostate cancer	3.46e-05	0.0124	CrCbGaD
Fluoxymesterone—Amcinonide—NR3C1—prostate cancer	3.46e-05	0.0124	CrCbGaD
Fluoxymesterone—Norethindrone—SHBG—prostate cancer	3.43e-05	0.0123	CrCbGaD
Fluoxymesterone—Danazol—AR—prostate cancer	3.38e-05	0.0121	CrCbGaD
Fluoxymesterone—Headache—Prednisone—prostate cancer	3.37e-05	0.000697	CcSEcCtD
Fluoxymesterone—Mometasone—NR3C1—prostate cancer	3.29e-05	0.0118	CrCbGaD
Fluoxymesterone—Methyltestosterone—SHBG—prostate cancer	3.26e-05	0.0116	CrCbGaD
Fluoxymesterone—Spironolactone—AR—prostate cancer	3.24e-05	0.0116	CrCbGaD
Fluoxymesterone—Nausea—Prednisone—prostate cancer	3.2e-05	0.000661	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Epirubicin—prostate cancer	3.1e-05	0.000641	CcSEcCtD
Fluoxymesterone—Medroxyprogesterone Acetate—AR—prostate cancer	3.03e-05	0.0109	CrCbGaD
Fluoxymesterone—Fludrocortisone—NR3C1—prostate cancer	2.9e-05	0.0104	CrCbGaD
Fluoxymesterone—Clobetasol propionate—NR3C1—prostate cancer	2.9e-05	0.0104	CrCbGaD
Fluoxymesterone—Progesterone—CYP17A1—prostate cancer	2.88e-05	0.0103	CrCbGaD
Fluoxymesterone—Hypersensitivity—Doxorubicin—prostate cancer	2.87e-05	0.000593	CcSEcCtD
Fluoxymesterone—Methyltestosterone—AR—prostate cancer	2.86e-05	0.0102	CrCbGaD
Fluoxymesterone—Danazol—CYP19A1—prostate cancer	2.83e-05	0.0101	CrCbGaD
Fluoxymesterone—Fluorometholone—NR3C1—prostate cancer	2.8e-05	0.01	CrCbGaD
Fluoxymesterone—Progesterone—SLC22A3—prostate cancer	2.75e-05	0.00984	CrCbGaD
Fluoxymesterone—Norethindrone—CYP3A5—prostate cancer	2.73e-05	0.00977	CrCbGaD
Fluoxymesterone—Headache—Epirubicin—prostate cancer	2.64e-05	0.000545	CcSEcCtD
Fluoxymesterone—Clobetasol propionate—CYP1A1—prostate cancer	2.64e-05	0.00943	CrCbGaD
Fluoxymesterone—Dexamethasone—CYP17A1—prostate cancer	2.64e-05	0.00943	CrCbGaD
Fluoxymesterone—Danazol—ESR1—prostate cancer	2.6e-05	0.00931	CrCbGaD
Fluoxymesterone—Testosterone—SLC22A3—prostate cancer	2.6e-05	0.0093	CrCbGaD
Fluoxymesterone—Nausea—Epirubicin—prostate cancer	2.5e-05	0.000517	CcSEcCtD
Fluoxymesterone—Prednisolone—CYP2A6—prostate cancer	2.47e-05	0.00884	CrCbGaD
Fluoxymesterone—Hydrocortisone—SHBG—prostate cancer	2.45e-05	0.00877	CrCbGaD
Fluoxymesterone—Headache—Doxorubicin—prostate cancer	2.44e-05	0.000504	CcSEcCtD
Fluoxymesterone—Methyltestosterone—CYP19A1—prostate cancer	2.39e-05	0.00855	CrCbGaD
Fluoxymesterone—Medroxyprogesterone Acetate—ESR1—prostate cancer	2.34e-05	0.00836	CrCbGaD
Fluoxymesterone—Nausea—Doxorubicin—prostate cancer	2.32e-05	0.000478	CcSEcCtD
Fluoxymesterone—Betamethasone—CYP19A1—prostate cancer	2.31e-05	0.00825	CrCbGaD
Fluoxymesterone—Triamcinolone—NR3C1—prostate cancer	2.28e-05	0.00816	CrCbGaD
Fluoxymesterone—Spironolactone—NR3C1—prostate cancer	2.2e-05	0.00785	CrCbGaD
Fluoxymesterone—Hydrocortamate—CYP3A4—prostate cancer	2.16e-05	0.00772	CrCbGaD
Fluoxymesterone—Cortisone acetate—CYP3A4—prostate cancer	2.12e-05	0.0076	CrCbGaD
Fluoxymesterone—Medroxyprogesterone Acetate—NR3C1—prostate cancer	2.06e-05	0.00736	CrCbGaD
Fluoxymesterone—Progesterone—SHBG—prostate cancer	2e-05	0.00715	CrCbGaD
Fluoxymesterone—Progesterone—CYP1B1—prostate cancer	2e-05	0.00715	CrCbGaD
Fluoxymesterone—Progesterone—SLC22A1—prostate cancer	1.97e-05	0.00705	CrCbGaD
Fluoxymesterone—Hydrocortisone—CYP3A5—prostate cancer	1.95e-05	0.00699	CrCbGaD
Fluoxymesterone—Prednisolone—NR3C1—prostate cancer	1.91e-05	0.00682	CrCbGaD
Fluoxymesterone—Testosterone—SHBG—prostate cancer	1.89e-05	0.00676	CrCbGaD
Fluoxymesterone—Testosterone—CYP1B1—prostate cancer	1.89e-05	0.00676	CrCbGaD
Fluoxymesterone—Betamethasone—NR3C1—prostate cancer	1.87e-05	0.00668	CrCbGaD
Fluoxymesterone—Eplerenone—CYP3A4—prostate cancer	1.86e-05	0.00667	CrCbGaD
Fluoxymesterone—Testosterone—SLC22A1—prostate cancer	1.86e-05	0.00667	CrCbGaD
Fluoxymesterone—Norethindrone—CYP2C19—prostate cancer	1.86e-05	0.00665	CrCbGaD
Fluoxymesterone—Dexamethasone—CYP1B1—prostate cancer	1.83e-05	0.00654	CrCbGaD
Fluoxymesterone—Progesterone—AR—prostate cancer	1.75e-05	0.00627	CrCbGaD
Fluoxymesterone—Testosterone—AR—prostate cancer	1.66e-05	0.00592	CrCbGaD
Fluoxymesterone—Fluorometholone—CYP3A4—prostate cancer	1.62e-05	0.0058	CrCbGaD
Fluoxymesterone—Progesterone—CYP3A5—prostate cancer	1.59e-05	0.00569	CrCbGaD
Fluoxymesterone—Progesterone—CYP2A6—prostate cancer	1.54e-05	0.00551	CrCbGaD
Fluoxymesterone—Testosterone—CYP3A5—prostate cancer	1.5e-05	0.00538	CrCbGaD
Fluoxymesterone—Hydrocortisone—NR3C1—prostate cancer	1.46e-05	0.00522	CrCbGaD
Fluoxymesterone—Dexamethasone—CYP3A5—prostate cancer	1.46e-05	0.00521	CrCbGaD
Fluoxymesterone—Dexamethasone—CYP2A6—prostate cancer	1.41e-05	0.00504	CrCbGaD
Fluoxymesterone—Testosterone—CYP19A1—prostate cancer	1.39e-05	0.00496	CrCbGaD
Fluoxymesterone—Progesterone—ESR1—prostate cancer	1.35e-05	0.00483	CrCbGaD
Fluoxymesterone—Dexamethasone—CYP19A1—prostate cancer	1.34e-05	0.0048	CrCbGaD
Fluoxymesterone—Danazol—CYP3A4—prostate cancer	1.33e-05	0.00475	CrCbGaD
Fluoxymesterone—Triamcinolone—CYP3A4—prostate cancer	1.32e-05	0.00473	CrCbGaD
Fluoxymesterone—Triamcinolone—PTGS2—prostate cancer	1.29e-05	0.00463	CrCbGaD
Fluoxymesterone—Medroxyprogesterone Acetate—CYP3A4—prostate cancer	1.19e-05	0.00427	CrCbGaD
Fluoxymesterone—Progesterone—NR3C1—prostate cancer	1.19e-05	0.00425	CrCbGaD
Fluoxymesterone—Norethindrone—CYP3A4—prostate cancer	1.18e-05	0.00423	CrCbGaD
Fluoxymesterone—Methyltestosterone—CYP3A4—prostate cancer	1.12e-05	0.00402	CrCbGaD
Fluoxymesterone—Prednisolone—CYP3A4—prostate cancer	1.11e-05	0.00395	CrCbGaD
Fluoxymesterone—Dexamethasone—NR3C1—prostate cancer	1.09e-05	0.00389	CrCbGaD
Fluoxymesterone—Progesterone—CYP2C19—prostate cancer	1.08e-05	0.00387	CrCbGaD
Fluoxymesterone—Betamethasone—CYP3A4—prostate cancer	1.08e-05	0.00387	CrCbGaD
Fluoxymesterone—Progesterone—CYP1A1—prostate cancer	1.08e-05	0.00386	CrCbGaD
Fluoxymesterone—Betamethasone—PTGS2—prostate cancer	1.06e-05	0.00379	CrCbGaD
Fluoxymesterone—Testosterone—CYP2C19—prostate cancer	1.02e-05	0.00366	CrCbGaD
Fluoxymesterone—Testosterone—CYP1A1—prostate cancer	1.02e-05	0.00365	CrCbGaD
Fluoxymesterone—Dexamethasone—CYP2E1—prostate cancer	1e-05	0.00358	CrCbGaD
Fluoxymesterone—Dexamethasone—CYP2C19—prostate cancer	9.91e-06	0.00354	CrCbGaD
Fluoxymesterone—Dexamethasone—CYP1A1—prostate cancer	9.87e-06	0.00353	CrCbGaD
Fluoxymesterone—Hydrocortisone—CYP3A4—prostate cancer	8.46e-06	0.00302	CrCbGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	7.85e-06	0.000138	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	7.79e-06	0.000137	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	7.77e-06	0.000136	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TP53—prostate cancer	7.72e-06	0.000135	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PLXNB1—prostate cancer	7.72e-06	0.000135	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	7.69e-06	0.000135	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	7.62e-06	0.000134	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—FGF2—prostate cancer	7.61e-06	0.000133	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—VEGFA—prostate cancer	7.56e-06	0.000132	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—EGFR—prostate cancer	7.52e-06	0.000132	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—VDR—prostate cancer	7.5e-06	0.000132	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NOS3—prostate cancer	7.5e-06	0.000132	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	7.48e-06	0.000131	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—ESR1—prostate cancer	7.44e-06	0.000131	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GRPR—prostate cancer	7.43e-06	0.00013	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	7.41e-06	0.00013	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—VDR—prostate cancer	7.39e-06	0.00013	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—JAK2—prostate cancer	7.29e-06	0.000128	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MYC—prostate cancer	7.25e-06	0.000127	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	7.24e-06	0.000127	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	7.22e-06	0.000127	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	7.2e-06	0.000126	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL17RD—prostate cancer	7.18e-06	0.000126	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MDM2—prostate cancer	7.12e-06	0.000125	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—KRAS—prostate cancer	7.11e-06	0.000125	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—EGFR—prostate cancer	7.09e-06	0.000124	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—EGFR—prostate cancer	7.05e-06	0.000124	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ERBB2—prostate cancer	7.02e-06	0.000123	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CB—prostate cancer	6.92e-06	0.000121	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	6.89e-06	0.000121	CbGpPWpGaD
Fluoxymesterone—Progesterone—CYP3A4—prostate cancer	6.89e-06	0.00246	CrCbGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL6—prostate cancer	6.89e-06	0.000121	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—RPS19—prostate cancer	6.89e-06	0.000121	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—DNMT3B—prostate cancer	6.82e-06	0.00012	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NR3C1—prostate cancer	6.75e-06	0.000118	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—DNMT3B—prostate cancer	6.72e-06	0.000118	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	6.7e-06	0.000117	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—KRAS—prostate cancer	6.69e-06	0.000117	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—RPL10—prostate cancer	6.69e-06	0.000117	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—KRAS—prostate cancer	6.66e-06	0.000117	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CXCL8—prostate cancer	6.65e-06	0.000117	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	6.62e-06	0.000116	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—RPL10—prostate cancer	6.59e-06	0.000116	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—DNMT1—prostate cancer	6.58e-06	0.000115	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—HIST1H2BG—prostate cancer	6.57e-06	0.000115	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PIK3CA—prostate cancer	6.53e-06	0.000114	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	6.53e-06	0.000114	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—CREBBP—prostate cancer	6.52e-06	0.000114	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—AKT1—prostate cancer	6.52e-06	0.000114	CbGpPWpGaD
Fluoxymesterone—Testosterone—CYP3A4—prostate cancer	6.51e-06	0.00233	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—CDKN1B—prostate cancer	6.5e-06	0.000114	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—HIST1H2BG—prostate cancer	6.47e-06	0.000113	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NCOA2—prostate cancer	6.46e-06	0.000113	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	6.4e-06	0.000112	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—JUP—prostate cancer	6.4e-06	0.000112	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—WNT4—prostate cancer	6.4e-06	0.000112	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—EZH2—prostate cancer	6.37e-06	0.000112	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CASP3—prostate cancer	6.37e-06	0.000112	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL2—prostate cancer	6.36e-06	0.000111	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—HIST1H4H—prostate cancer	6.34e-06	0.000111	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NPPA—prostate cancer	6.34e-06	0.000111	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—PPARA—prostate cancer	6.33e-06	0.000111	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—CYP3A4—prostate cancer	6.3e-06	0.00225	CrCbGaD
Fluoxymesterone—NR3C1—Gene Expression—HIST1H4H—prostate cancer	6.25e-06	0.00011	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NPPA—prostate cancer	6.25e-06	0.00011	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MED12—prostate cancer	6.24e-06	0.000109	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PARP1—prostate cancer	6.24e-06	0.000109	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—PPARA—prostate cancer	6.23e-06	0.000109	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCND1—prostate cancer	6.2e-06	0.000109	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—PTGS2—prostate cancer	6.17e-06	0.00221	CrCbGaD
Fluoxymesterone—NR3C1—Gene Expression—MED12—prostate cancer	6.14e-06	0.000108	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CTNNB1—prostate cancer	6.14e-06	0.000108	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PIK3CA—prostate cancer	6.12e-06	0.000107	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—SERPINE1—prostate cancer	6.12e-06	0.000107	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RALBP1—prostate cancer	6.1e-06	0.000107	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MC2R—prostate cancer	6.1e-06	0.000107	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IL6—prostate cancer	6.05e-06	0.000106	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MMP9—prostate cancer	6.02e-06	0.000106	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	6e-06	0.000105	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CDKN1A—prostate cancer	6e-06	0.000105	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	5.99e-06	0.000105	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PTEN—prostate cancer	5.98e-06	0.000105	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TP53—prostate cancer	5.95e-06	0.000104	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—HSPA1A—prostate cancer	5.91e-06	0.000104	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—ESR2—prostate cancer	5.91e-06	0.000104	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	5.87e-06	0.000103	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL6—prostate cancer	5.78e-06	0.000101	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EP300—prostate cancer	5.71e-06	0.0001	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—ESR1—prostate cancer	5.65e-06	9.9e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SRC—prostate cancer	5.55e-06	9.73e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	5.55e-06	9.73e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NCOA1—prostate cancer	5.44e-06	9.55e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PENK—prostate cancer	5.44e-06	9.54e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—IL6—prostate cancer	5.42e-06	9.5e-05	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	5.4e-06	9.48e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—VEGFA—prostate cancer	5.4e-06	9.48e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—STAT3—prostate cancer	5.35e-06	9.38e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—AKT1—prostate cancer	5.33e-06	9.35e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—RPS19—prostate cancer	5.31e-06	9.3e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL6—prostate cancer	5.23e-06	9.16e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—RPS19—prostate cancer	5.22e-06	9.16e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GHR—prostate cancer	5.19e-06	9.1e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—RXRA—prostate cancer	5.18e-06	9.08e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	5.1e-06	8.94e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—DNMT1—prostate cancer	5.07e-06	8.89e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—CREBBP—prostate cancer	5.03e-06	8.81e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—AKT1—prostate cancer	5.02e-06	8.81e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—AKT1—prostate cancer	5e-06	8.76e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—DNMT1—prostate cancer	4.99e-06	8.76e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NCOA2—prostate cancer	4.98e-06	8.73e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NRP1—prostate cancer	4.98e-06	8.73e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MYC—prostate cancer	4.97e-06	8.72e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TGFB1—prostate cancer	4.96e-06	8.7e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—CREBBP—prostate cancer	4.95e-06	8.68e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	4.93e-06	8.65e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—EZH2—prostate cancer	4.91e-06	8.61e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NCOA2—prostate cancer	4.9e-06	8.59e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EGFR—prostate cancer	4.86e-06	8.53e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—EZH2—prostate cancer	4.84e-06	8.48e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PARP1—prostate cancer	4.81e-06	8.43e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—SIRT1—prostate cancer	4.76e-06	8.34e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PARP1—prostate cancer	4.73e-06	8.3e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—SERPINE1—prostate cancer	4.71e-06	8.26e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—VDR—prostate cancer	4.69e-06	8.22e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—SERPINE1—prostate cancer	4.64e-06	8.14e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GNRH1—prostate cancer	4.63e-06	8.11e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—VIP—prostate cancer	4.63e-06	8.11e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—KRAS—prostate cancer	4.59e-06	8.06e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—HSPA1A—prostate cancer	4.55e-06	7.98e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—ESR2—prostate cancer	4.55e-06	7.98e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—HSPA1A—prostate cancer	4.48e-06	7.86e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ESR2—prostate cancer	4.48e-06	7.86e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GRP—prostate cancer	4.48e-06	7.86e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LPAR1—prostate cancer	4.48e-06	7.86e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PLCB2—prostate cancer	4.44e-06	7.78e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LRP2—prostate cancer	4.44e-06	7.78e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CX3CL1—prostate cancer	4.35e-06	7.63e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—P4HB—prostate cancer	4.35e-06	7.63e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—ERCC2—prostate cancer	4.29e-06	7.52e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HIST1H2BG—prostate cancer	4.27e-06	7.49e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PDE4D—prostate cancer	4.23e-06	7.42e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GRB7—prostate cancer	4.23e-06	7.42e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NR3C1—prostate cancer	4.22e-06	7.4e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CA—prostate cancer	4.22e-06	7.4e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NCOA1—prostate cancer	4.19e-06	7.35e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	4.16e-06	7.3e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NCOA1—prostate cancer	4.13e-06	7.24e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HIST1H4H—prostate cancer	4.12e-06	7.23e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TP53—prostate cancer	4.08e-06	7.16e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GNG5—prostate cancer	4.02e-06	7.06e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—AR—prostate cancer	4.02e-06	7.05e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—RXRA—prostate cancer	3.99e-06	6.99e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—AR—prostate cancer	3.96e-06	6.94e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PPARA—prostate cancer	3.96e-06	6.94e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—RXRA—prostate cancer	3.93e-06	6.89e-05	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—MYC—prostate cancer	3.87e-06	6.79e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL6—prostate cancer	3.74e-06	6.55e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—SIRT1—prostate cancer	3.67e-06	6.43e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—VDR—prostate cancer	3.61e-06	6.33e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SIRT1—prostate cancer	3.61e-06	6.33e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—ESR1—prostate cancer	3.58e-06	6.28e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—VDR—prostate cancer	3.56e-06	6.24e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTHLH—prostate cancer	3.51e-06	6.15e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TGFBR1—prostate cancer	3.51e-06	6.15e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKR1C3—prostate cancer	3.45e-06	6.05e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AKT1—prostate cancer	3.45e-06	6.05e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PRKACB—prostate cancer	3.43e-06	6.02e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—THBS1—prostate cancer	3.34e-06	5.86e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PPP3CA—prostate cancer	3.34e-06	5.86e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—ERCC2—prostate cancer	3.3e-06	5.79e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ANXA1—prostate cancer	3.3e-06	5.78e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ERCC2—prostate cancer	3.25e-06	5.71e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NR3C1—prostate cancer	3.25e-06	5.7e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PRKCZ—prostate cancer	3.24e-06	5.67e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—CREBBP—prostate cancer	3.14e-06	5.51e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PARP1—prostate cancer	3.12e-06	5.48e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FGFR4—prostate cancer	3.12e-06	5.48e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CALCA—prostate cancer	3.09e-06	5.41e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PPARA—prostate cancer	3.05e-06	5.34e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CXCL12—prostate cancer	3.01e-06	5.29e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PPARA—prostate cancer	3e-06	5.26e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—MYC—prostate cancer	2.98e-06	5.23e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—SERPINE1—prostate cancer	2.95e-06	5.16e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—MYC—prostate cancer	2.94e-06	5.15e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CASP9—prostate cancer	2.84e-06	4.98e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NGFR—prostate cancer	2.75e-06	4.82e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PRKCQ—prostate cancer	2.75e-06	4.82e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ESR1—prostate cancer	2.72e-06	4.77e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAP3K7—prostate cancer	2.72e-06	4.77e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FGF10—prostate cancer	2.61e-06	4.58e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ADRB2—prostate cancer	2.59e-06	4.54e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—VAV3—prostate cancer	2.52e-06	4.42e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TGFBR2—prostate cancer	2.49e-06	4.36e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ITPR1—prostate cancer	2.45e-06	4.29e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—CREBBP—prostate cancer	2.42e-06	4.24e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—CREBBP—prostate cancer	2.38e-06	4.18e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IGF1R—prostate cancer	2.34e-06	4.1e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—SERPINE1—prostate cancer	2.27e-06	3.98e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LPL—prostate cancer	2.24e-06	3.93e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SERPINE1—prostate cancer	2.23e-06	3.92e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PDGFRB—prostate cancer	2.22e-06	3.9e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ITGB3—prostate cancer	2.17e-06	3.8e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ERBB3—prostate cancer	2.1e-06	3.68e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FGFR2—prostate cancer	2.1e-06	3.68e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TERT—prostate cancer	2.01e-06	3.53e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HIF1A—prostate cancer	1.93e-06	3.38e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LEP—prostate cancer	1.88e-06	3.3e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MYC—prostate cancer	1.86e-06	3.27e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CAV1—prostate cancer	1.86e-06	3.27e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KDR—prostate cancer	1.84e-06	3.23e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—BAD—prostate cancer	1.75e-06	3.07e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APC—prostate cancer	1.7e-06	2.97e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CG—prostate cancer	1.7e-06	2.97e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IRS1—prostate cancer	1.68e-06	2.94e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EGF—prostate cancer	1.68e-06	2.94e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GSK3B—prostate cancer	1.63e-06	2.85e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—INS—prostate cancer	1.61e-06	2.82e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CREBBP—prostate cancer	1.57e-06	2.76e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IGF1—prostate cancer	1.55e-06	2.72e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAP2K1—prostate cancer	1.5e-06	2.63e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CD—prostate cancer	1.49e-06	2.62e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SERPINE1—prostate cancer	1.48e-06	2.59e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MYC—prostate cancer	1.44e-06	2.52e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FGF2—prostate cancer	1.43e-06	2.5e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MYC—prostate cancer	1.41e-06	2.48e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NOS3—prostate cancer	1.41e-06	2.47e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—JAK2—prostate cancer	1.37e-06	2.4e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MDM2—prostate cancer	1.34e-06	2.34e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ERBB2—prostate cancer	1.32e-06	2.31e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CB—prostate cancer	1.3e-06	2.28e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—AKT1—prostate cancer	1.29e-06	2.27e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CXCL8—prostate cancer	1.25e-06	2.19e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CDKN1B—prostate cancer	1.22e-06	2.14e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CASP3—prostate cancer	1.2e-06	2.1e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL2—prostate cancer	1.19e-06	2.09e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCND1—prostate cancer	1.16e-06	2.04e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CTNNB1—prostate cancer	1.15e-06	2.02e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MMP9—prostate cancer	1.13e-06	1.98e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CDKN1A—prostate cancer	1.13e-06	1.97e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTEN—prostate cancer	1.12e-06	1.97e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EP300—prostate cancer	1.07e-06	1.88e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SRC—prostate cancer	1.04e-06	1.83e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—VEGFA—prostate cancer	1.01e-06	1.78e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—STAT3—prostate cancer	1e-06	1.76e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—AKT1—prostate cancer	9.96e-07	1.75e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—AKT1—prostate cancer	9.81e-07	1.72e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MYC—prostate cancer	9.34e-07	1.64e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TGFB1—prostate cancer	9.31e-07	1.63e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EGFR—prostate cancer	9.13e-07	1.6e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KRAS—prostate cancer	8.63e-07	1.51e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CA—prostate cancer	7.93e-07	1.39e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TP53—prostate cancer	7.67e-07	1.34e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL6—prostate cancer	7.02e-07	1.23e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKT1—prostate cancer	6.47e-07	1.14e-05	CbGpPWpGaD
